Millennium Management
LAB icon

Millennium Management’s Standard BioTools LAB Stock Holding History

Millennium Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,400
Closed -$32.2K – 6159
2024
Q4 		$32.2K Buy
+18,400
New +$34.3K ﹤0.01% 5657

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Millennium Management's LAB Position: Q1 2026 in Review

Millennium Management reduced its Standard BioTools (LAB) stake by 38% in Q1 2026, selling an estimated $1.56M and leaving 2,102,015 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3903.

Millennium Management first reported a position in LAB in Q2 2013 and has held it in 51 quarters since. The position peaked at $39M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Millennium Management held 2,102,015 shares of Standard BioTools worth $1.93M as of Q1 2026.
  • Millennium Management sold 1,285,413 Standard BioTools shares in Q1 2026, an estimated $1.56M.
  • Standard BioTools made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3903 holding.
  • Millennium Management first reported a position in Standard BioTools in Q2 2013 and has held it in 51 quarters since.
  • Millennium Management's Standard BioTools position peaked at $39M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.